Australia's most trusted
source of pharma news
Sunday, 29 September 2024
Posted 25 June 2024 AM
Johnson & Johnson has been named as the world's most valuable pharma brand for the sixth consecutive year.
Despite breaking off many of its recognisable products into stand-alone consumer healthcare company Kenvue, the pharma giant retained its top-ranking position and increased its brand value by five per cent this year, to AU$20.1 billion (US$13.4 billion).
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.